Previous 10 | Next 10 |
Reports Net Revenues of $112.2 Million for the Three Months Ended September 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / November 8, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2021. ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / October 28, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2021 ended September 30, 2021, after the market closes on Monday, November 8, 2021, and will hold a conference call to...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event. For further details see: Amphastar Pharmaceuticals (AMPH) 2021 Wells Fargo Virtual Healthcare Conference- Slideshow
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Amphastar Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2021 Earnings Conference Call August 09, 2021, 17:00 ET Company Participants Dan Dischner - VP, Corporate Communications William Peters - CFO, Treasurer & EVP, Finance Tony Marrs - SVP, Regulatory Affairs and Clinical Operations Conference Call Pa...
Image source: The Motley Fool. Amphastar Pharmaceuticals, inc (NASDAQ: AMPH) Q2 2021 Earnings Call Aug 9, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Amphastar Pharmaceuticals, inc (AMPH) Q2 2021 Earnings Call T...
Reports Net Revenues of $101.7 Million for the Three Months Ended June 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / August 9, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended June 30, 2021. Second Qu...
RANCHO CUCAMONGA, CA / ACCESSWIRE / July 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2021 ended June 30, 2021, after the market closes on Monday, August 9 th , 2021, and will hold a conference call to disc...
RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawa...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...